Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BTG PLC announces EkoSonic Endovascular System receives FDA Clearance for treatment of pulmonary embolism in USA


Friday, 23 May 2014 02:02am EDT 

BTG PLC:EKOS Corp, BTG International group company announced US FDA has cleared EkoSonic Endovascular System.EkoSonic Endovascular system for ultrasound facilitated, controlled and selective infusion of physician-specified fluids, including thrombolytics, into vasculature for treatment of pulmonary embolism.EKOS ultrasonic devices are designed to gently accelerate penetration of thrombolytic agents into thrombus, providing high levels of lysis.EKOS is only minimally invasive endovascular therapy on market that has been FDA cleared for treatment of PE. 

Company Quote

734.0
12.0 +1.66%
1 May 2015